Teva Pharmaceutical Industries Limited ( TEVA) - Key Metrics
TEVA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.18 | $0.43 | $1.33 | $1.20 |
| 2025Q3 | $3.91 | $0.38 | $0.32 | $0.20 |
| 2025Q2 | $3.64 | $0.25 | $0.20 | $0.11 |
| 2025Q1 | $3.42 | $0.19 | -$0.09 | -$0.20 |
TEVA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 18.57 |
| 2025Q3 | ? | 12.87 |
| 2025Q2 | ? | 17.14 |
| 2025Q1 | ? | 19.93 |
TEVA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.60% | ? |
| 2025Q4 | 2.83% | ? |
| 2025Q3 | 1.01% | ? |
| 2025Q2 | 0.68% | ? |
| 2025Q1 | -1.33% | ? |
TEVA
Price: $34.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.34 USD
P/E Ratio: 26.76
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Israel
Volume: 6.4 million
Ebitda: -12.5 billionMarket Capitalization: 38.2 billion